News & Press.
Learn the Latest Aziyo Updates
Aziyo Biologics and Boston Scientific Corporation Enter U.S. Sales Agent Agreement for CanGaroo® Envelope
Boston Scientific Sales Agents to Begin Selling Aziyo’s CanGaroo May 1st SILVER SPRING, MD. – May 1, 2019 – Aziyo Biologics, Inc., a fully integrated, commercially oriented regenerative medicine company, announced that it has entered into a U.S....
Aziyo Announces Publication of RECON Study of Pericardial Reconstruction Using ProxiCor
Prospective Study of 1,420 Patients Showed Statistically Significant Reduction in Post-Operative Complications and 30-Day Hospital Readmission Rates SILVER SPRING, MD. – April 9, 2019 – Aziyo®Biologics, Inc., a fully integrated regenerative...
Aziyo’s CanGaroo Envelope Cleared for Expanded Use with Neurostimulator Devices
SILVER SPRING, MD. – November 29, 2018 – Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced today that it has received U.S. Food and Drug Administration (FDA) clearance of the CanGaroo Envelope device for use with...
RTI Surgical® and Aziyo Biologics® Announce Exclusive Agreement to Distribute ViBone® for Spine and Other Orthopedic Procedures
Agreement will expand availability of ViBone, a next generation cellular bone matrix product ALACHUA, Fla. and Silver Spring, Md. – August 1, 2018 – RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, and Aziyo Biologics, Inc., a...
Aziyo Partners with SurGenTec for Minimally Invasive Bone Graft Delivery
ViBone viable bone matrix in GraftGun to be marketed for minimally invasive spine and orthopedic surgery SILVER SPRING, MD. – July 13, 2018 – Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced today it has entered...